-
30 countries launch initiative to share COVID-19 tools
expresspharma
June 02, 2020
It comes amid concerns that rich countries pumping resources into finding will muscle their way to the front of the queue, once a candidate succeeds.
-
Pharma leaders, policy makers discuss COVID-19 impact, way forward for industry
expresspharma
June 02, 2020
Most are optimistic about the future but accentuate the need for investments in technology and other strategic measures to ensure progress.
-
CordenPharma & Moderna Extend Manufacturing Agreement
contractpharma
June 01, 2020
For the supply of lipid excipients to be used in Moderna's coronavirus vaccine.
-
AstraZeneca says it may consider exposing vaccine trial participants to virus
expresspharma
June 01, 2020
The British drugmaker last week started phase 2 and 3 trials of the vaccine, looking to recruit around 10,000 adults and children in Britain.
-
New vaccine for prevention of Ebola virus disease recommended for approval in the EU
expresspharma
June 01, 2020
The new Ebola vaccine consists of two components, Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo). Zabdeno is given first and Mvabea is administered approximately eight weeks later as a booster.
-
Operation Warp Speed: developing, manufacturing and distributing COVID-19 medical countermeasures
europeanpharmaceuticalreview
May 26, 2020
Exploring Operation Warp Speed, the Trump Administration’s program to expedite R&D, manufacturing and distribution of medical countermeasures for COVID-19.
-
Two malaria vaccine candidates show signs of efficacy
europeanpharmaceuticalreview
May 26, 2020
Clinical trials testing potential malaria vaccines report the vaccines were well tolerated and demonstrated some efficacy, delaying Plasmodium falciparum infection.
-
Akers, Premas Biotech Announce Successful Completion of Vaccine Prototype
americanpharmaceuticalreview
May 20, 2020
Akers Biosciences announced Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic, has successfully completed its vaccine prototype.
-
Premas Biotech announces completion of vaccine prototype of triple-antigen candidate against COVID-1
expresspharma
May 20, 2020
Reportedly, the vaccine prototype is among the first in the world for VLP of SARS CoV-2 virus.
-
US likely to get first access to Sanofi’s Covid-19 vaccine candidate
pharmaceutical-technology
May 15, 2020
French pharmaceutical giant Sanofi CEO Paul Hudson has said that the US will likely have first access to its Covid-19 vaccine if it succeeds.